Cargando…

Economic Evaluations of Mass Drug Administration: The Importance of Economies of Scale and Scope

It is recognized that changing the current approaches for the control of the neglected tropical diseases will be needed to reach the World Health Organization’s (WHO) 2020 goals. Consequently, it is important that economic evaluations of the alternative approaches are conducted. A vital component of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turner, Hugo C, Toor, Jaspreet, Hollingsworth, T Déirdre, Anderson, Roy M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888956/ https://www.ncbi.nlm.nih.gov/pubmed/29126255 http://dx.doi.org/10.1093/cid/cix1001

Ejemplares similares

Valuing the Unpaid Contribution of Community Health Volunteers to Mass Drug Administration Programs
por: Turner, Hugo C, et al.
Publicado: (2019)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
por: Kura, Klodeta, et al.
Publicado: (2020)

Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
por: Kura, Klodeta, et al.
Publicado: (2020)

Should the Goal for the Treatment of Soil Transmitted Helminth (STH) Infections Be Changed from Morbidity Control in Children to Community-Wide Transmission Elimination?
por: Anderson, Roy M., et al.
Publicado: (2015)

Strengthening data collection for neglected tropical diseases: What data are needed for models to better inform tailored intervention programmes?
por: Toor, Jaspreet, et al.
Publicado: (2021)

Assessing the Impact of a Missed Mass Drug Administration in Haiti
por: Won, Kimberly Y., et al.
Publicado: (2009)

Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
por: Kura, Klodeta, et al.
Publicado: (2019)

The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths
por: Anderson, Roy, et al.
Publicado: (2014)

Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
por: Collyer, Benjamin S., et al.
Publicado: (2019)

Mass drug administration for the prevention human strongyloidiasis should consider concomitant treatment of dogs
por: Beknazarova, Meruyert, et al.
Publicado: (2017)

Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
por: Kura, Klodeta, et al.
Publicado: (2021)

The past matters: estimating intrinsic hookworm transmission intensity in areas with past mass drug administration to control lymphatic filariasis
por: Werkman, Marleen, et al.
Publicado: (2017)

Antibacterial mass drug administration for child mortality reduction: Opportunities, concerns, and possible next steps
por: Bogoch, Isaac I., et al.
Publicado: (2019)

Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
por: Toor, Jaspreet, et al.
Publicado: (2020)

Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment
por: Ayabina, Diepreye, et al.
Publicado: (2021)

Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection
por: Khan, Abdul Mabood
Publicado: (2018)

One drug to treat them all: ethical implications of the MORDOR trial of mass antibiotic administration to reduce child mortality
por: Tam, Clarence C, et al.
Publicado: (2019)

Increasing the Impact of JMIR Journals in the Attention Economy
por: Leung, Ricky
Publicado: (2019)

Enhancing onchocerciasis elimination program management: A biological approach to deciding when to begin Stop Mass Drug Administration activities
por: Boakye, Daniel, et al.
Publicado: (2023)

Vietnam: Neglected tropical diseases in an emerging and accelerating economy
por: Pham, Kala, et al.
Publicado: (2022)

Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
por: Bustinduy, Amaya L., et al.
Publicado: (2016)

Collaborating in the Time of COVID-19: The Scope and Scale of Innovative Responses to a Global Pandemic
por: Bernardo, Theresa, et al.
Publicado: (2021)

The political economy of health in the Gaza strip: Reversing de-development
por: Jebril, Mona, et al.
Publicado: (2022)

The Role of the Sharing Economy and Artificial Intelligence in Health Care: Opportunities and Challenges
por: Wu, Huailiang, et al.
Publicado: (2019)

Rethinking Data Sharing at the Dawn of a Health Data Economy: A Viewpoint
por: Tang, Chunlei, et al.
Publicado: (2018)

From Africa to the World: Reimagining Africa’s research capacity and culture in the global knowledge economy
por: Olufadewa, Isaac Iyinoluwa, et al.
Publicado: (2020)

Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration
por: Choy, Robert K. M., et al.
Publicado: (2020)

Measuring and modelling the effects of systematic non-adherence to mass drug administration
por: Dyson, Louise, et al.
Publicado: (2017)

Diagnosing risk factors alongside mass drug administration using serial diagnostic tests—which test first?
por: Dyson, Louise, et al.
Publicado: (2018)

Improving Access to Medicines for Neglected Tropical Diseases in Developing Countries: Lessons from Three Emerging Economies
por: Holt, Francesca, et al.
Publicado: (2012)

Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration
por: Werkman, Marleen, et al.
Publicado: (2018)

The Increasing Scope of Teledermatology in Nepal
por: Paudel, Vikash
Publicado: (2020)

The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
por: Mathew, Christopher G, et al.
Publicado: (2020)

Introduction to Endo-ERN–scope and mission
por: Pereira, Alberto M., et al.
Publicado: (2021)

Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation
por: Toor, Jaspreet, et al.
Publicado: (2020)

A Call to Expand the Scope of Digital Phenotyping
por: De Boer, Christopher, et al.
Publicado: (2023)

The Importance of Pathogen Load
por: Cunnington, Aubrey J.
Publicado: (2015)

Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs
por: Turner, Hugo C., et al.
Publicado: (2020)

Assessment of economic vulnerability to infectious disease crises
por: Sands, Peter, et al.
Publicado: (2016)

The Economics of Revision Arthroplasty for Periprosthetic Joint Infection
por: Roof, Mackenzie A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_91pn35tp2e8lp7g3s0itjlktek